The trial enrolled 210 patients in the darovasertib combination arm and 103 in the ICT arm.

By Puyaan Singh April 13 (Reuters) - IDEAYA Biosciences and French pharma company Servier said on Monday their combination ...

Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being ...

"It's common that companies invest a lot in fermentation and not that much in downstream process development," says Wagner ...

Chinese Premier Li Qiang has signed a decree of the State Council to publish a new set of rules on countering foreign states' ...

UniX AI, a global humanoid robotics service provider specializing in R&D, mass production, and real-world deployment of ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company received a complete ...

The site access road is set to be the “major arm”, with the existing cul-de-sac to the north becoming the “minor arm”. A ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced ...

This is part of our commitment to making sure every Kansas Citian has access to safe, quality affordable housing. We’re ...